These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25927679)

  • 1. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
    Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward immunomodulatory and anti-inflammatory properties of statins.
    Arnaud C; Braunersreuther V; Mach F
    Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and myocardial infarction: Type, dose, and administration time: Does it matter?
    Papageorgiou N; Zacharia E; Briasoulis A; Androulakis E; Tousoulis D
    Trends Cardiovasc Med; 2016 Jul; 26(5):433-41. PubMed ID: 26948202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia Part 2: Review of Dyslipidemia Treatment in Patients With Noncoronary Vascular Disease.
    Gonzalez L; Helkin A; Gahtan V
    Vasc Endovascular Surg; 2016 Feb; 50(2):119-35. PubMed ID: 26983668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis: can statins play a dual role?
    Rajpara AN; Goldner R; Gaspari A
    Dermatol Online J; 2010 Feb; 16(2):2. PubMed ID: 20178698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic effects of statins: new therapeutic targets in drug design.
    Bedi O; Dhawan V; Sharma PL; Kumar P
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):695-712. PubMed ID: 27146293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.
    Egom EE; Rose RA; Neyses L; Soran H; Cleland JG; Mamas MA
    Crit Rev Clin Lab Sci; 2013; 50(3):79-89. PubMed ID: 23885725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
    Kratzer A; Giral H; Landmesser U
    Cardiovasc Res; 2014 Aug; 103(3):350-61. PubMed ID: 24935432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and prevention of venous thromboembolism: Myth or reality?
    Gaertner S; Cordeanu EM; Nouri S; Mirea C; Stephan D
    Arch Cardiovasc Dis; 2016 Mar; 109(3):216-22. PubMed ID: 26778087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary and Secondary Prevention of Acute Coronary Syndromes: The Role of the Statins.
    Diamantis E; Troupis T; Mazarakis A; Kyriakos G; Diamanti S; Troupis G; Skandalakis P
    Recent Adv Cardiovasc Drug Discov; 2014; 9(2):97-105. PubMed ID: 26152179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis.
    Blum A; Shamburek R
    Atherosclerosis; 2009 Apr; 203(2):325-30. PubMed ID: 18834985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia.
    Oesterle A; Liao JK
    Curr Vasc Pharmacol; 2019; 17(3):222-232. PubMed ID: 30124154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual risk and high-density lipoprotein cholesterol levels: is there a relationship?
    Shah PK
    Rev Cardiovasc Med; 2011; 12(2):e55-9. PubMed ID: 21796083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do statins have a role in reduction/prevention of post-PCI restenosis?
    Prasad K
    Cardiovasc Ther; 2013 Feb; 31(1):12-26. PubMed ID: 21967674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?
    Heeneman S; Donners MM; Bai L; Daemen MJ
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):345-64. PubMed ID: 17338677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and the endothelium.
    Ii M; Losordo DW
    Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.